Terms: = Colorectal cancer AND SDHC, CYBL, 6391, ENSG00000143252, SDH3, PGL3, QPS1, CYB560
25 results:
1. Deficiency of sdhc promotes metastasis by reprogramming fatty acid metabolism in colorectal cancer.
Ding Z; Wei Y; Dai J; Pan C; Yang L; Li Q; Zhang Y; Yan Q; Wu C; Li A; Lan Z; Liu S; Wang X
J Transl Med; 2024 Jun; 22(1):544. PubMed ID: 38844980
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
[TBL] [Abstract] [Full Text] [Related]
3. Variations in the Type of Adjuvant Chemotherapy Among Stage III Colon cancer Patients in England.
Hassan S; Miles A; Rachet B; Morris M
J Gastrointest Cancer; 2023 Dec; 54(4):1193-1201. PubMed ID: 36602753
[TBL] [Abstract] [Full Text] [Related]
4. BRAF V600E Mutation in First-Line Metastatic colorectal cancer: An Analysis of Individual Patient Data From the ARCAD Database.
Cohen R; Liu H; Fiskum J; Adams R; Chibaudel B; Maughan TS; Van Cutsem E; Venook A; Douillard JY; Heinemann V; Ja Punt C; Falcone A; Bokemeyer C; Kaplan R; Lenz HJ; Koopman M; Yoshino T; Zalcberg J; Grothey A; de Gramont A; Shi Q; André T
J Natl Cancer Inst; 2021 Oct; 113(10):1386-1395. PubMed ID: 33734401
[TBL] [Abstract] [Full Text] [Related]
5. A prospective multicenter phase II study on the efficacy and safety of dasatinib in the treatment of metastatic gastrointestinal stromal tumors failed by imatinib and sunitinib and analysis of NGS in peripheral blood.
Zhou Y; Zhang X; Wu X; Zhou Y; Zhang B; Liu X; Wu X; Li Y; Shen L; Li J
Cancer Med; 2020 Sep; 9(17):6225-6233. PubMed ID: 32677196
[TBL] [Abstract] [Full Text] [Related]
6. A Circulating miRNA-Based Scoring System Established by WGCNA to Predict Colon cancer.
Qin D; Wei R; Liu S; Zhu S; Zhang S; Min L
Anal Cell Pathol (Amst); 2019; 2019():1571045. PubMed ID: 31871878
[TBL] [Abstract] [Full Text] [Related]
7. Ileal intubation is not associated with higher detection rate of right-sided conventional adenomas and serrated polyps compared to cecal intubation after adjustment for overall adenoma detection rate.
Buerger M; Kasper P; Allo G; Gillessen J; Schramm C
BMC Gastroenterol; 2019 Nov; 19(1):190. PubMed ID: 31730463
[TBL] [Abstract] [Full Text] [Related]
8. Downregulation of miR‑143 modulates KRAS expression in colorectal carcinoma cells.
Liu H; Liu J; Huo J; Li K; Li K; Guo H; Yang Y
Oncol Rep; 2019 Dec; 42(6):2759-2767. PubMed ID: 31638218
[TBL] [Abstract] [Full Text] [Related]
9. Significant association between KDM1A promoter hypomethylation and colorectal cancer in Han Chinese.
Zhong J; Pan R; Ying X; Wu B; Zhou C; Wu D; Ying J; Duan S
Pathol Res Pract; 2019 Mar; 215(3):532-538. PubMed ID: 30638951
[TBL] [Abstract] [Full Text] [Related]
10. Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women.
Wang X; Shojaie A; Zhang Y; Shelley D; Lampe PD; Levy L; Peters U; Potter JD; White E; Lampe JW
PLoS One; 2017; 12(5):e0178444. PubMed ID: 28542447
[TBL] [Abstract] [Full Text] [Related]
11. A functional variant rs353292 in the flanking region of miR-143/145 contributes to the risk of colorectal cancer.
Yuan F; Sun R; Li L; Jin B; Wang Y; Liang Y; Che G; Gao L; Zhang L
Sci Rep; 2016 Jul; 6():30195. PubMed ID: 27444415
[TBL] [Abstract] [Full Text] [Related]
12. A risk prediction model for colorectal cancer using genome-wide association study-identified polymorphisms and established risk factors among Japanese: results from two independent case-control studies.
Hosono S; Ito H; Oze I; Watanabe M; Komori K; Yatabe Y; Shimizu Y; Tanaka H; Matsuo K
Eur J Cancer Prev; 2016 Nov; 25(6):500-7. PubMed ID: 26637073
[TBL] [Abstract] [Full Text] [Related]
13. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
Hu S; Liu L; Chang EB; Wang JY; Raufman JP
Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
[TBL] [Abstract] [Full Text] [Related]
14. Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer.
Dong G; He X; Chen Y; Cao H; Wang J; Liu X; Wang S; Wan S; Xing J
Mol Cancer; 2015 Sep; 14():171. PubMed ID: 26377099
[TBL] [Abstract] [Full Text] [Related]
15. MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells.
Xiang KM; Li XR
Asian Pac J Cancer Prev; 2014; 15(8):3767-72. PubMed ID: 24870791
[TBL] [Abstract] [Full Text] [Related]
16. Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan.
Nørgaard A; Dam C; Jakobsen A; Pløen J; Lindebjerg J; Rafaelsen SR
Scand J Gastroenterol; 2014 Feb; 49(2):202-8. PubMed ID: 24279811
[TBL] [Abstract] [Full Text] [Related]
17. The -1195G allele increases the transcriptional activity of cyclooxygenase-2 gene (COX-2) in colon cancer cell lines.
Pereira C; Sousa H; Silva J; Brandão C; Elgueta-Karstegl C; Farrell PJ; Medeiros R; Dinis-Ribeiro M
Mol Carcinog; 2014 Feb; 53 Suppl 1():E92-5. PubMed ID: 23776069
[TBL] [Abstract] [Full Text] [Related]
18. Reduced succinate dehydrogenase B expression is associated with growth and de-differentiation of colorectal cancer cells.
Zhang D; Wang W; Xiang B; Li N; Huang S; Zhou W; Sun Y; Wang X; Ma J; Li G; Li X; Shen S
Tumour Biol; 2013 Aug; 34(4):2337-47. PubMed ID: 23645213
[TBL] [Abstract] [Full Text] [Related]
19. Colon cancer associated genes exhibit signatures of positive selection at functionally significant positions.
Morgan CC; Shakya K; Webb A; Walsh TA; Lynch M; Loscher CE; Ruskin HJ; O'Connell MJ
BMC Evol Biol; 2012 Jul; 12():114. PubMed ID: 22788692
[TBL] [Abstract] [Full Text] [Related]
20. [The effect of RhoE on CD44 promoter and the malignant behaviors of colorectal cancer cell].
Zhou HJ; Li LL; Yue CX; Wei W; Li NJ; Tang QL; Bi F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):589-93. PubMed ID: 22007478
[TBL] [Abstract] [Full Text] [Related]
[Next]